US5268176A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and compositions for the non-invasive treatment of telangiectasia
Assignee: Avon Products Inc
•
Filing: 1991-07-22
•
Granted: 1993-12-07
•
Expires: 2011-07-22
Abstract
Abstract This invention is directed to a non-invasive, topical treatment for telangiectasia, a dermatological condition commonly known as spider veins. The treatment preferably includes repeated applications of a composition having an effective amount of an inositol phosphoric acid or derivatives and mixtures thereof. Inositol hexaphosphate (phytic acid) is most preferred, with or without the use of a compression stocking.
Inventors
- 👤 Alexander P. Znaiden
- 👤 George P. Serban
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 17:54
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
59 words
A method for treating telangiectasia which comprises the topical application of a composition to an area affected by telangiectasia, wherein said composition includes an effective amount of a member selected from the group consisting of inositol phosphoric acid, its sulfuryl derivative and its carboxyl derivative and mixtures thereof in the range from about 3 percent to about 100 percent.
Claim 2
Independent Claim
59 words
A method for treating telangiectasia which comprises the topical application of a composition to an area affected by telangiectasia, wherein said composition includes an effective amount of a member selected from the group consisting of inositol phosphoric acid, its sulfuryl derivative and its carboxyl derivative and mixtures thereof in the range from about 3 percent to about 100 percent.
Claim 3
Dependent Claim
13 words
The method of claim 1, wherein said derivative is inositol hexaphosphate (phytic acid).
Claim 4
Dependent Claim
14 words
The method of claim 1, wherein said effective amount is at least 3 percent.
Claim 5
Dependent Claim
21 words
The method of claim 1, wherein said effective amount is in the range from about 5 percent to about 50 percent.
Claim 6
Dependent Claim
21 words
The method of claim 4, wherein said effective amount is in the range from about 15 percent to about 30 percent.
Claim 7
Dependent Claim
19 words
The method of claim 1, which further comprises daily topical applications for a period of two to 14 days.
Claim 8
Dependent Claim
13 words
The method of claim 1, which further comprises application of a compression bandage.
Claim 9
Dependent Claim
13 words
The method of claim 1, wherein said composition further comprises a vasoactive agent.
Claim 10
Dependent Claim
13 words
The method of claim 1, wherein said composition further comprises a buffering agent.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-12-06 | 1997-06-07 | 1997-12-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-12-06 | 2001-06-07 | 2001-12-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-12-06 | 2005-06-07 | 2005-12-07 | $7700.00 | Window Closed / Lapsed |